These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 33292596)
1. Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia. Zheng R; Li M; Wang S; Liu Y Exp Hematol Oncol; 2020 Nov; 9(1):31. PubMed ID: 33292596 [TBL] [Abstract][Full Text] [Related]
2. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. Hales EC; Taub JW; Matherly LH Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475 [TBL] [Abstract][Full Text] [Related]
3. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257 [TBL] [Abstract][Full Text] [Related]
4. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Pear WS; Aster JC Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998 [TBL] [Abstract][Full Text] [Related]
5. Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts. Minuzzo S; Agnusdei V; Pinazza M; Amaro AA; Sacchetto V; Pfeffer U; Bertorelle R; Spinelli O; Serafin V; Indraccolo S Exp Hematol Oncol; 2023 Sep; 12(1):76. PubMed ID: 37667380 [TBL] [Abstract][Full Text] [Related]
6. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia. Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570 [TBL] [Abstract][Full Text] [Related]
7. How I treat T-cell acute lymphoblastic leukemia in adults. Litzow MR; Ferrando AA Blood; 2015 Aug; 126(7):833-41. PubMed ID: 25966987 [TBL] [Abstract][Full Text] [Related]
8. The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy. Tosello V; Ferrando AA Ther Adv Hematol; 2013 Jun; 4(3):199-210. PubMed ID: 23730497 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of γ-secretase activity synergistically enhances tumour necrosis factor-related apoptosis-inducing ligand induced apoptosis in T-cell acute lymphoblastic leukemia cells via upregulation of death receptor 5. Greene LM; Nathwani SM; Zisterer DM Oncol Lett; 2016 Oct; 12(4):2900-2905. PubMed ID: 27698877 [TBL] [Abstract][Full Text] [Related]
10. Gamma-secretase inhibitors suppress the growth of leukemia and lymphoma cells. Kogoshi H; Sato T; Koyama T; Nara N; Tohda S Oncol Rep; 2007 Jul; 18(1):77-80. PubMed ID: 17549349 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of Notch signaling and immune checkpoint blockade in a spontaneous, genetically heterogeneous mouse model of T-cell acute lymphoblastic leukemia. Gao J; Van Meter M; Hernandez Lopez S; Chen G; Huang Y; Ren S; Zhao Q; Rojas J; Gurer C; Thurston G; Kuhnert F Dis Model Mech; 2019 Sep; 12(9):. PubMed ID: 31399482 [TBL] [Abstract][Full Text] [Related]
12. Recent advances on NOTCH signaling in T-ALL. Tzoneva G; Ferrando AA Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746 [TBL] [Abstract][Full Text] [Related]
13. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications. Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993 [TBL] [Abstract][Full Text] [Related]
15. CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia. Liu J; Zhang X; Zhong JF; Zhang C Immunotherapy; 2017 Oct; 9(13):1115-1125. PubMed ID: 29032733 [TBL] [Abstract][Full Text] [Related]
16. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation. Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318 [TBL] [Abstract][Full Text] [Related]
17. The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects. Fattizzo B; Rosa J; Giannotta JA; Baldini L; Fracchiolla NS Front Oncol; 2020; 10():273. PubMed ID: 32185137 [TBL] [Abstract][Full Text] [Related]
18. PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature. Efimenko E; Davé UP; Lebedeva IV; Shen Y; Sanchez-Quintero MJ; Diolaiti D; Kung A; Lannutti BJ; Chen J; Realubit R; Niatsetskaya Z; Ten V; Karan C; Chen X; Califano A; Diacovo TG Mol Cancer Ther; 2017 Oct; 16(10):2069-2082. PubMed ID: 28716817 [TBL] [Abstract][Full Text] [Related]
19. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387 [TBL] [Abstract][Full Text] [Related]
20. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia. Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]